Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashwin Ajay

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Expert Opinion on Investigational Drugs|December 6, 2024
Relaxin agonists under preclinical and early clinical investigation for the treatment of heart failureAshwin Ajay, Priyanga Biju, Hanan Ajay, et al.
European Cardiology|January 12, 2024
Alcohol and Heart FailureDebar Rasoul, Ashwin Ajay, Alend Abdullah, et al.
Expert Opinion on Investigational Drugs|November 30, 2023
Augmentation of natriuretic peptide (NP) receptor A and B (NPR-A and NPR-B) and cyclic guanosine monophosphate (cGMP) signalling as a therapeutic strategy in heart failureAshwin Ajay, Debar Rasoul, Alend Abdullah, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Expert Opinion on Investigational Drugs|December 6, 2024
Relaxin agonists under preclinical and early clinical investigation for the treatment of heart failureAshwin Ajay, Priyanga Biju, Hanan Ajay, et al.
European Cardiology|January 12, 2024
Alcohol and Heart FailureDebar Rasoul, Ashwin Ajay, Alend Abdullah, et al.
Expert Opinion on Investigational Drugs|November 30, 2023
Augmentation of natriuretic peptide (NP) receptor A and B (NPR-A and NPR-B) and cyclic guanosine monophosphate (cGMP) signalling as a therapeutic strategy in heart failureAshwin Ajay, Debar Rasoul, Alend Abdullah, et al.
Pageof 1